Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Die Abteilung Dermatologie am Universitätsklinikum Dresden forscht im Rahmen des Skin Cancer Center und des UCC/NCT Dresden an immunologischen Mechanismen der Melanomprogression. Im PhD-Projekt arbeiten Sie mit patientenabgeleiteten Proben und nutzen Spatial- und Immunprofiling-Ansätze, um Immunantworten mit klinischen Outcomes zu verknüpfen.
Die Stelle ist Teil eines interdisziplinären Teams, bietet Mitarbeit in internationalen Kollaborationen, eine Vergütung gemäß TV-L E13 und eine 65%-Stelle
The Skin Cancer Center at the Department of Dermatology is part of the University Cancer Center (UCC) and the National Center for Tumor Diseases (NCT) Dresden and provides comprehensive interdisciplinary care for patients with malignant skin tumors. Alongside patient care, clinical and translational research is a major focus of our work. Our translational research laboratory, “Experimental Dermato-Oncology,” investigates the immune mechanisms underlining skin cancer progression and therapy response, with the aim of identifying novel biomarkers and therapeutic strategies. The laboratory is closely connected to clinical and scientific partners at University Hospital Dresden, including Immunology and Pathology, and collaborates with national and international research partners, including through the German Consortium for Translational Cancer Research (DKTK) and the NCT.
In this PhD project, we aim to uncover immune mechanisms that shape melanoma progression, systemic anti-tumor immunity and clinical outcome. Using well-characterized patient-derived tissue and blood samples, we will investigate how the immune microenvironment and systemic immune responses differ between patients with distinct clinical courses. The project will integrate spatial and quantitative tissue analysis with immunological and molecular approaches, linking experimental findings to detailed clinical data and long-term patient outcomes. Modern technologies including spatial biology, digital pathology and immune profiling will be complemented by functional experimental approaches to investigate biologically relevant findings in greater depth. By studying patients across different clinical and therapeutic settings, we aim to identify immune features associated with melanoma progression and outcome and to better understand how local and systemic immune responses contribute to disease control. The specific biological questions and methodological focus will evolve throughout the project based on emerging findings, providing opportunities to develop and pursue novel mechanistic hypotheses.
The Skin Cancer Center at the Department of Dermatology is part of the University Cancer Center (UCC) and the National Center for Tumor Diseases (NCT) Dresden and provides comprehensive interdisciplinary care for patients with malignant skin tumors. Alongside patient care, clinical and translational research is a major focus of our work. Our translational research laboratory, “Experimental Dermato-Oncology,” investigates the immune mechanisms underlining skin cancer progression and therapy response, with the aim of identifying novel biomarkers and therapeutic strategies. The laboratory is closely connected to clinical and scientific partners at University Hospital Dresden, including Immunology and Pathology, and collaborates with national and international research partners, including through the German Consortium for Translational Cancer Research (DKTK) and the NCT.
In this PhD project, we aim to uncover immune mechanisms that shape melanoma progression, systemic anti-tumor immunity and clinical outcome. Using well-characterized patient-derived tissue and blood samples, we will investigate how the immune microenvironment and systemic immune responses differ between patients with distinct clinical courses. The project will integrate spatial and quantitative tissue analysis with immunological and molecular approaches, linking experimental findings to detailed clinical data and long-term patient outcomes. Modern technologies including spatial biology, digital pathology and immune profiling will be complemented by functional experimental approaches to investigate biologically relevant findings in greater depth. By studying patients across different clinical and therapeutic settings, we aim to identify immune features associated with melanoma progression and outcome and to better understand how local and systemic immune responses contribute to disease control. The specific biological questions and methodological focus will evolve throughout the project based on emerging findings, providing opportunities to develop and pursue novel mechanistic hypotheses.
in the Experimental Dermato-Oncology laboratory of the Department of Dermatology at the University Hospital Dresden (Franklin group)
The position is available as soon as possible on a part‑time basis (26 hours per week, 65%) and is limited to 36 months. Remuneration is based on the collective agreement for the public service of the German federal states (TV-L) and may be classified up to pay grade E13, depending on the applicant's qualifications.
Please be advised that a valid work permit for Germany is required for non‑EU citizens. Unfortunately, applications without a valid work permit and sufficient German language skills may not be considered.
LNKD1_DE